Accéder au contenu
Merck

Genomic and Proteomic Resolution of Heterochromatin and Its Restriction of Alternate Fate Genes.

Molecular cell (2017-12-23)
Justin S Becker, Ryan L McCarthy, Simone Sidoli, Greg Donahue, Kelsey E Kaeding, Zhiying He, Shu Lin, Benjamin A Garcia, Kenneth S Zaret
RÉSUMÉ

Heterochromatin is integral to cell identity maintenance by impeding the activation of genes for alternate cell fates. Heterochromatic regions are associated with histone 3 lysine 9 trimethylation (H3K9me3) or H3K27me3, but these modifications are also found in euchromatic regions that permit transcription. We discovered that resistance to sonication is a reliable indicator of the heterochromatin state, and we developed a biophysical method (gradient-seq) to discriminate subtypes of H3K9me3 and H3K27me3 domains in sonication-resistant heterochromatin (srHC) versus euchromatin. These classifications are more accurate than the histone marks alone in predicting transcriptional silence and resistance of alternate fate genes to activation during direct cell conversion. Our proteomics of H3K9me3-marked srHC and functional screens revealed diverse proteins, including RBMX and RBMXL1, that impede gene induction during cellular reprogramming. Isolation of srHC with gradient-seq provides a genome-wide map of chromatin structure, elucidating subtypes of repressed domains that are uniquely predictive of diverse other chromatin properties.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Sérum d'âne
Sigma-Aldrich
Milieu essentiel minimum d′Eagle, With Earle′s salts and sodium bicarbonate, without L-glutamine, liquid, sterile-filtered, suitable for cell culture
Sigma-Aldrich
L-Proline, from non-animal source, meets EP, USP testing specifications, suitable for cell culture
Sigma-Aldrich
Insulin-transferrin-sodium selenite media supplement, γ-irradiated, lyophilized powder, BioXtra, suitable for cell culture
Sigma-Aldrich
D-(+)-galactose, ≥99% (HPLC)
Sigma-Aldrich
L-(−)-Galactose, ≥99% (HPLC)
Sigma-Aldrich
MISSION® esiRNA, targeting human RBMX
Sigma-Aldrich
MISSION® esiRNA, targeting human SUV39H1